Products Lasmiditan was approved in the United States in 2019 in film-coated tablet form (Reyvow). Structure and properties Lasmiditan (C19H18F3N3O2, Mr = 377.4 g/mol) is present in the drug as lasmiditanhemisuccinate, a white crystalline powder that is sparingly soluble in water. It is a piperidine and pyridine derivative and has no indole structure. Effects Lasmiditan … Lasmiditan
Products Raloxifene is commercially available in the form of film-coated tablets (Evista). It has been approved in many countries since 2000. Structure and properties Raloxifene (C28H27NO4S, Mr = 473.6 g/mol) is present in the drug as raloxifene hydrochloride, a benzothiophene and white to yellowish powder that is sparingly soluble in water. Effects Raloxifene (ATC G03XC01) … Raloxifene
Products Pyrantel is commercially available in the form of chewable tablets and oral suspension and is available in many countries without a doctor’s prescription (Cobantril, originally: Combantrin). It has been approved since 1971 and is also commonly used as a veterinary drug. Structure and properties Pyrantel (C11H14N2S, Mr = 206.3 g/mol) is present in the … Pyrantel
Products Opipramol is commercially available in the form of dragées (Insidon). It has been approved in many countries since 1961, originally by Geigy, later by Novartis. Structure and properties Opipramol (C23H29N3O, Mr = 363.5 g/mol) structurally belongs to the tricyclic antidepressants and is a dibenzazepine derivative. It is present in the drug as opipramol dihydrochloride. … Opipramol
Products Oxycodone is commercially available in the form of sustained-release tablets, capsules, melting tablets, as an injectable, and drops (including Oxycontin, Oxynorm, and generics). It has been used medicinally for decades. In the U.S., it is also used as a fix in combination with other analgesics such as acetaminophen (e.g., Percocet). Oxycodone is also available … Oxycodone: Drug Effects, Side Effects, Dosage and Uses
Products Phenylephrine is commercially available in the form of nasal drops, as a nasal spray, nasal gel, eye drops, oral powder, as an injectable, and in capsules as a mono- or combination preparation (e.g., Neo-Citran, Triofan Rhinitis Capsules, Vibrocil). It has been approved in many countries since 1968. Rhinopront is off the market. See also … Phenylephrine
Products Flibanserin (Addyi) was approved in the United States in 2015 in the form of film-coated tablets. The drug has not yet been registered in many countries. Flibanserin was originally developed at Boehringer Ingelheim as an antidepressant. It was marketed in the United States by Sprout Pharmaceuticals. Structure and properties Flibanserin (C20H21F3N4O, Mr = 390.4 … Flibanserin
